Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT07227480
Official study title

Advancing Lung Cancer Screening One Text at a Time

Study summary

The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedText messaging program and Educational material

The study team can explain what participation involves.

Who it may be forLung Cancer Screening

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 19, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Rochester

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of Rochester
Interventions being studied
Behavioral: Text messaging program; Behavioral: Educational material
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 50 to 80 years old
  • have not completed their annual screening for lung cancer
  • have a 20 pack-year smoking history
  • currently smoke or have quit within the past 15 years
  • speak English and/or Spanish
  • have a functioning cellphone number with unlimited text messaging capacity
  • be willing to complete a baseline and a follow-up (at Month 3) survey
Reasons someone may not be able to joinExclusion criteria

being up-to-date on their annual lung cancer screening

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Rochester Medical CenterRochester, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 19, 2026. Always confirm current availability with the study team.

View original record ↗